GILD vs OPCH · P/E 18, rev $7.80B vs P/E 24, rev $5.65B
Gilead Sciences Inc (GILD) versus Option Care Health Inc (OPCH) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Option Care Health Inc (OPCH) is a medical care facilities company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported OPCH revenue for 2025-12-31 was $5.65B. Net income was $207.6M. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. OPCH currently screens at market cap $4.99B and trailing P/E 23.9.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. OPCH currently screens at market cap $4.99B and trailing P/E 23.9.
Not investment advice. Open the GILD and OPCH stock pages for the full models.
Not investment advice.